ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,747Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 324

$572K Total Retail Price of All Prescriptions

Rank: 79 out of 324

335 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 335 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 5,370 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 399 238 1 3
LEVOTHYROXINE SODIUM 348 184 2 2
METFORMIN HCL 268 169 3 9
SIMVASTATIN 264 119 4 1
HYDROCODONE-ACETAMINOPHEN 263 81 S3 5 5
AMLODIPINE BESYLATE 259 203 6 4
OMEPRAZOLE 219 136 7 6
NEXIUM 185 64 8 33
FLUTICASONE PROPIONATE 172 90 9 32
FUROSEMIDE 157 104 10 7
METOPROLOL SUCCINATE 145 112 11 17
ATORVASTATIN CALCIUM 129 97 12 12
GABAPENTIN 123 70 13 13
CYCLOBENZAPRINE HCL 120 45 R 14 51
TRAMADOL HCL 109 55 15 19
CIPROFLOXACIN HCL 105 54 16 55
SERTRALINE HCL 103 55 17 23
NAPROXEN 102 54 18 132
TRAZODONE HCL 101 25 19 42
TAMSULOSIN HCL 96 91 20 26
ZOLPIDEM TARTRATE 92 47 21 20
CELEBREX 91 65 22 96
METHOCARBAMOL 90 36 R 23 226
AZITHROMYCIN 89 45 24 48
CARVEDILOL 89 41 24 22
CLOPIDOGREL 89 73 24 38
FENOFIBRATE 86 52 27 79
POTASSIUM CHLORIDE 83 42 28 8
DOXYCYCLINE HYCLATE 78 37 29 78
CITALOPRAM HBR 76 41 30 16
METOPROLOL TARTRATE 74 45 31 14
CRESTOR 74 53 31 28
LOSARTAN POTASSIUM 74 65 31 15
LYRICA 71 12 34 107
ADVAIR DISKUS 71 52 34 61
GLIPIZIDE 70 66 36 73
HYDROCHLOROTHIAZIDE 67 44 37 11
WARFARIN SODIUM 66 17 38 10
LIDODERM 65 61 39 110
AMITRIPTYLINE HCL 65 51 R 39 66
MUPIROCIN 63 35 41 189
PROAIR HFA 63 36 41 50
DONEPEZIL HCL 63 62 41 25
ATENOLOL 62 50 44 18
OXYCODONE HCL-ACETAMINOPHEN 61 0 S2 45 105
PLAVIX 60 49 46 63
FLUOXETINE HCL 58 29 47 67
PANTOPRAZOLE SODIUM 57 45 48 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 31 49 91
FLUCONAZOLE 56 14 49 180
BUPROPION HCL SR 55 16 51 157
LANTUS 54 23 52 39
METOCLOPRAMIDE HCL 54 16 52 125
TOPIRAMATE 51 34 54 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.